Inventor
FANG QUN KEVIN
US28 patents
⚠️ This page may combine multiple inventors who share the name “FANG QUN KEVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEPRACOR INC
16 patentsUS7087785B2Aug 8, 2006
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
SEPRACOR INC28 citations96
US6337328B1Jan 8, 2002
Bupropion metabolites and methods of use
SEPRACOR INC59 citations94
US7790772B2Sep 7, 2010
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SEPRACOR INC15 citations92
US7589237B2Sep 15, 2009
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SEPRACOR INC14 citations92
US7423179B2Sep 9, 2008
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SEPRACOR INC12 citations92
US7105699B2Sep 12, 2006
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
SEPRACOR INC18 citations92
US7579370B2Aug 25, 2009
Fused heterocycles
SEPRACOR INC25 citations91
US6780891B2Aug 24, 2004
Tramadol analogs and uses thereof
SEPRACOR INC20 citations91
US5925761AJul 20, 1999
Synthesis of terfenadine and derivatives
SEPRACOR INC18 citations90
US6710087B2Mar 23, 2004
Methods of treating or preventing neuropathic pain using sibutramine metabolites
SEPRACOR INC7 citations72
US6399826B1Jun 4, 2002
Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
SEPRACOR INC7 citations72
US6025177AFeb 15, 2000
Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
SEPRACOR INC7 citations71
US7902252B2Mar 8, 2011
Inhibitors of D-amino acid oxidase
SEPRACOR INC4 citations61
US6147217ANov 14, 2000
Synthesis of terfenadine and derivatives
SEPRACOR INC3 citations60
US6974838B2Dec 13, 2005
Methods of treating or preventing pain using sibutramine metabolites
SEPRACOR INC0 citations50
US6013830AJan 11, 2000
Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
SEPRACOR INC1 citations49
SUNOVION PHARMACEUTICALS INC
8 patentsUS9072699B2Jul 7, 2015
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SUNOVION PHARMACEUTICALS INC4 citations84
US8344030B2Jan 1, 2013
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SUNOVION PHARMACEUTICALS INC3 citations73
US10702486B2Jul 7, 2020
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US10328036B2Jun 25, 2019
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US9907764B2Mar 6, 2018
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US9498452B2Nov 22, 2016
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US8658700B2Feb 25, 2014
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US9884844B2Feb 6, 2018
Heterocyclic compounds and methods of use thereof
SUNOVION PHARMACEUTICALS INC1 citations51